Canadian Manufacturing

IntelGenx enters first agreement for CDMO packaging services

by CM staff   

Financing Manufacturing CDMO IntelGenx packaging services revenue stream

Expected to generate approximately $9 million in revenue for IntelGenx over three years.

SAINT LAURENT — IntelGenx Corp., has entered into a binding term sheet agreement for the packaging of a pharmaceutical oral film product that its undisclosed CDMO customer is planning to commercialize in the United States. IntelGenx will package (film in pouch) the product at its cGMP manufacturing facility in Montreal.

Subject to satisfaction of remaining conditions, the parties will endeavor to enter into a definitive agreement as soon as is practicable.

“In addition to providing us with a meaningful new revenue stream, this first commercial-scale packaging agreement helps validate our ability to further expand our CDMO business by providing additional services to both end-to-end CDMO services clients as well as on a stand-alone project basis to key players in the Canadian and U.S. markets,” commented Dwight Gorham, IntelGenx’s CEO. “We are looking forward to building a strong partnership.”
About IntelGenx

IntelGenx is a drug delivery company focused on the development and manufacturing of pharmaceutical films.


IntelGenx’s superior film technologies, including VersaFilm®, DisinteQ™, VetaFilm® and transdermal VevaDerm™, allow for next generation pharmaceutical products that address unmet medical needs. IntelGenx’s innovative product pipeline offers significant benefits to patients and physicians for many therapeutic conditions.


Stories continue below